ENZON PHARMACEUTICALS, INC. Quarterly Operating Income (Loss) in USD from Q2 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Enzon Pharmaceuticals, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2010 to Q2 2024.
  • Enzon Pharmaceuticals, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$325K, a 2.2% decline year-over-year.
  • Enzon Pharmaceuticals, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$1.09M, a 5.51% decline year-over-year.
  • Enzon Pharmaceuticals, Inc. annual Operating Income (Loss) for 2023 was -$1.04M, a 1.16% decline from 2022.
  • Enzon Pharmaceuticals, Inc. annual Operating Income (Loss) for 2022 was -$1.03M, a 120% decline from 2021.
  • Enzon Pharmaceuticals, Inc. annual Operating Income (Loss) for 2021 was -$469K, a 64.1% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$1.09M -$325K -$7K -2.2% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 -$1.09M -$326K -$41K -14.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 -$1.04M -$216K -$5K -2.37% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-20
Q3 2023 -$1.04M -$225K -$4K -1.81% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 -$1.04M -$318K -$15K -4.95% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 -$1.02M -$285K +$12K +4.04% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 -$1.03M -$211K +$20K +8.66% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-20
Q3 2022 -$1.05M -$221K +$7K +3.07% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$1.06M -$303K -$282K -1343% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 -$777K -$297K -$308K -2800% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-05
Q4 2021 -$469K -$231K +$191K +45.3% Oct 1, 2021 Dec 31, 2021 10-K 2023-02-16
Q3 2021 -$660K -$228K +$179K +44% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 -$839K -$21K +$215K +91.1% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 -$1.05M $11K +$251K Jan 1, 2021 Mar 31, 2021 10-Q 2022-04-26
Q4 2020 -$1.31M -$422K -$164K -63.6% Oct 1, 2020 Dec 31, 2020 10-K 2022-02-25
Q3 2020 -$1.14M -$407K -$82K -25.2% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-05
Q2 2020 -$1.06M -$236K -$215K -1024% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 -$844K -$240K +$129K +35% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-04
Q4 2019 -$973K -$258K Oct 1, 2019 Dec 31, 2019 10-K 2021-02-23
Q3 2019 -$325K +$194K +37.4% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 -$21K +$185K +89.8% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-29
Q1 2019 -$369K Jan 1, 2019 Mar 31, 2019 10-Q 2020-04-30
Q3 2018 -$519K Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-06
Q2 2018 -$206K Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07
Q3 2016 $8.36M $1.61M +$2.54M Jul 1, 2016 Sep 30, 2016 10-Q 2016-11-10
Q2 2016 $5.83M $1.84M -$2.84M -60.7% Apr 1, 2016 Jun 30, 2016 10-Q 2016-08-10
Q1 2016 $8.67M $2.55M -$2.13M -45.6% Jan 1, 2016 Mar 31, 2016 10-Q 2016-05-09
Q4 2015 $10.8M $2.37M -$3.43M -59.1% Oct 1, 2015 Dec 31, 2015 10-K 2016-03-21
Q3 2015 $14.2M -$926K -$8.52M -112% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-10
Q2 2015 $22.7M $4.68M -$2.25M -32.5% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-10
Q1 2015 $25M $4.68M -$3.79M -44.8% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q4 2014 $28.8M $5.8M +$813K +16.3% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-21
Q3 2014 $28M $7.59M +$2.47M +48.2% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-06
Q2 2014 $25.5M $6.93M +$2.03M +41.4% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-07
Q1 2014 $23.5M $8.47M +$5.32M +169% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-13
Q4 2013 $18.2M $4.99M +$13.2M Oct 1, 2013 Dec 31, 2013 10-K 2015-03-05
Q3 2013 $4.94M $5.12M +$1.06M +26.1% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-06
Q2 2013 $3.88M $4.9M +$4.66M +1925% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-08
Q1 2013 -$780K $3.15M +$3.19M Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-09
Q4 2012 -$3.97M -$8.23M -$4.22M -105% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-14
Q3 2012 $252K $4.06M +$11.8M Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-12
Q2 2012 -$11.6M $242K +$6.24M Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-06
Q1 2012 -$17.8M -$36K -$1.36M -103% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-10
Q4 2011 -$16.5M -$4.02M Oct 1, 2011 Dec 31, 2011 10-K 2014-03-14
Q3 2011 -$7.76M -$369K -4.99% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-09
Q2 2011 -$6M -$925K -18.2% Apr 1, 2011 Jun 30, 2011 10-Q/A 2012-08-21
Q1 2011 $1.32M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-02
Q3 2010 -$7.39M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-04
Q2 2010 -$5.08M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.